Collectively, these data identify RRM2 as a proliferation-associated marker preferentially expressed in activated cytotoxic T cells, implicating its involvement in sustaining immune effector responses within the LUAD tumor microenvironment (TME). This evidence concerns the gene RRM2 and neoplasm.